88 related articles for article (PubMed ID: 22681384)
1. Development of a multiplex selected reaction monitoring assay for quantification of biochemical markers of down syndrome in amniotic fluid samples.
Martínez-Morillo E; Cho CK; Drabovich AP; Shaw JL; Soosaipillai A; Diamandis EP
J Proteome Res; 2012 Jul; 11(7):3880-7. PubMed ID: 22681384
[TBL] [Abstract][Full Text] [Related]
2. Specificity and sensitivity of S100B levels in amniotic fluid for Down syndrome diagnosis.
Tort AB; Portela LV; da Purificação Tavares M; Gonçalves CA; Netto C; Giugliani R; Souza DO
Life Sci; 2004 Dec; 76(4):379-84. PubMed ID: 15530500
[TBL] [Abstract][Full Text] [Related]
3. Periodic health examination, 1996 update: 1. Prenatal screening for and diagnosis of Down syndrome. Canadian Task Force on the Periodic Health Examination.
Dick PT
CMAJ; 1996 Feb; 154(4):465-79. PubMed ID: 8630836
[TBL] [Abstract][Full Text] [Related]
4. Decreased amniotic fluid leptin levels in the second trimester in Down's syndrome.
Choi TY; Kim S; An BM; Jeong SY; Moon HS; Joo BS
Fetal Diagn Ther; 2009; 26(4):195-9. PubMed ID: 19940449
[TBL] [Abstract][Full Text] [Related]
5. Amniotic fluid proteome analysis from Down syndrome pregnancies for biomarker discovery.
Cho CK; Smith CR; Diamandis EP
J Proteome Res; 2010 Jul; 9(7):3574-82. PubMed ID: 20459121
[TBL] [Abstract][Full Text] [Related]
6. Do amniotic fluid leptin levels decrease in pregnancies with fetal trisomy 21?
Demir A; Saatli B; Cagliyan E; Solak A; Guclu S
J Obstet Gynaecol; 2012 Aug; 32(6):540-2. PubMed ID: 22779957
[TBL] [Abstract][Full Text] [Related]
7. Verification of a biomarker discovery approach for detection of Down syndrome in amniotic fluid via multiplex selected reaction monitoring (SRM) assay.
Cho CK; Drabovich AP; Batruch I; Diamandis EP
J Proteomics; 2011 Sep; 74(10):2052-9. PubMed ID: 21624510
[TBL] [Abstract][Full Text] [Related]
8. [Assessment of AFP in amniotic fluid: comparison of three automated techniques].
Leguy MC; Tavares Sdos R; Tsatsaris V; Lewin F; Clauser E; Guibourdenche J
Ann Biol Clin (Paris); 2011; 69(4):441-6. PubMed ID: 21896409
[TBL] [Abstract][Full Text] [Related]
9. A folate-dependent metabolite in amniotic fluid from pregnancies with normal or trisomy 21 chromosomes.
Baggot PJ; Eliseo AJ; Kalamarides JA; Shoemaker JD
Fetal Diagn Ther; 2006; 21(1):148-52. PubMed ID: 16354994
[TBL] [Abstract][Full Text] [Related]
10. Proteomic analysis of maternal serum in down syndrome: identification of novel protein biomarkers.
Nagalla SR; Canick JA; Jacob T; Schneider KA; Reddy AP; Thomas A; Dasari S; Lu X; Lapidus JA; Lambert-Messerlian GM; Gravett MG; Roberts CT; Luthy D; Malone FD; D'Alton ME
J Proteome Res; 2007 Apr; 6(4):1245-57. PubMed ID: 17373838
[TBL] [Abstract][Full Text] [Related]
11. Human neutrophil collagenase (matrix metalloproteinase 8) in parturition, premature rupture of the membranes, and intrauterine infection.
Maymon E; Romero R; Pacora P; Gomez R; Athayde N; Edwin S; Yoon BH
Am J Obstet Gynecol; 2000 Jul; 183(1):94-9. PubMed ID: 10920315
[TBL] [Abstract][Full Text] [Related]
12. Proteomic analysis of amniotic fluid in pregnancies with Down syndrome.
Tsangaris GT; Karamessinis P; Kolialexi A; Garbis SD; Antsaklis A; Mavrou A; Fountoulakis M
Proteomics; 2006 Aug; 6(15):4410-9. PubMed ID: 16847874
[TBL] [Abstract][Full Text] [Related]
13. C-reactive protein concentration in vaginal fluid as a marker for intra-amniotic inflammation/infection in preterm premature rupture of membranes.
Shim SS; Romero R; Jun JK; Moon KC; Kim G; Yoon BH
J Matern Fetal Neonatal Med; 2005 Dec; 18(6):417-22. PubMed ID: 16390808
[TBL] [Abstract][Full Text] [Related]
14. Bead-based multiplexed immunoassays to identify new biomarkers in maternal serum to improve first trimester Down syndrome screening.
Koster MP; Pennings JL; Imholz S; Rodenburg W; Visser GH; de Vries A; Schielen PC
Prenat Diagn; 2009 Sep; 29(9):857-62. PubMed ID: 19488973
[TBL] [Abstract][Full Text] [Related]
15. Early oxidative stress in amniotic fluid of pregnancies with Down syndrome.
Perrone S; Longini M; Bellieni CV; Centini G; Kenanidis A; De Marco L; Petraglia F; Buonocore G
Clin Biochem; 2007 Feb; 40(3-4):177-80. PubMed ID: 17208212
[TBL] [Abstract][Full Text] [Related]
16. Amniotic fluid urocortin, CRF, oestriol, dehydroepiandrosterone sulfate and cortisol concentrations at mid-trimester: putative relationship with preterm delivery.
Torricelli M; Voltolini C; Galleri L; Biliotti G; Giovannelli A; De Bonis M; De Pascalis F; Centini G; Petraglia F
Eur J Obstet Gynecol Reprod Biol; 2009 Oct; 146(2):169-73. PubMed ID: 19619932
[TBL] [Abstract][Full Text] [Related]
17. Amniotic fluid levels of CA 19.9 and CA 15.3 in normal and Down's syndrome pregnancies.
Noci I; Borri P; Biagiotti R; Cariati E; Branconi F; Torricelli F; Cappelli G; D'Agata A
J Perinat Med; 1995; 23(3):237-41. PubMed ID: 8568617
[TBL] [Abstract][Full Text] [Related]
18. Comparative proteomic analysis of human amniotic fluid supernatants with Down syndrome using mass spectrometry.
Park J; Cha DH; Jung JW; Kim YH; Lee SH; Kim Y; Kim KP
J Microbiol Biotechnol; 2010 Jun; 20(6):959-67. PubMed ID: 20622492
[TBL] [Abstract][Full Text] [Related]
19. Urine hyperglycosylated hCG plus ultrasound biometry for detection of down syndrome in the second trimester in a high-risk population.
Bahado-Singh R; Oz U; Shahabi S; Omrani A; Mahoney M; Cole L
Obstet Gynecol; 2000 Jun; 95(6 Pt 1):889-94. PubMed ID: 10831986
[TBL] [Abstract][Full Text] [Related]
20. The evolving national birth prevalence of Down syndrome in Taiwan. A study on the impact of second-trimester maternal serum screening.
Jou HJ; Kuo YS; Hsu JJ; Shyu MK; Hsieh TT; Hsieh FJ
Prenat Diagn; 2005 Aug; 25(8):665-70. PubMed ID: 16049991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
